All Options USA’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
All Options USA's ANGO Position: Q2 2026 in Review
All Options USA sold out of AngioDynamics (ANGO) in Q2 2026, closing a stake of 29 shares — an estimated $330 sold.
All Options USA first reported a position in ANGO in Q1 2026 and held it in 1 quarter. The position peaked at $330 in Q1 2026. 163 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.
- All Options USA reported no remaining AngioDynamics position as of Q2 2026 after selling out during the quarter.
- All Options USA sold 29 AngioDynamics shares in Q2 2026, an estimated $330.
- All Options USA first reported a position in AngioDynamics in Q1 2026 and held it in 1 quarter.
- All Options USA's AngioDynamics position peaked at $330 in Q1 2026.
- 163 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.
Based on All Options USA's 13F filing for Q2 2026, filed 12 Nov 2026.